Evidence map›Paper›PMID 21821741›Full record

ArticleApplied and environmental microbiology2011

Salicylate functions as an efflux pump inducer and promotes the emergence of fluoroquinolone-resistant Campylobacter jejuni mutants.

Zhangqi Shen, Xiao-Ying Pu, Qijing Zhang

Open access · greenAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
6.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Impact ofMicrobiology spectrum · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Antimicrobial Resistance inMicrobiology spectrum · 2018
    Review
  9. Article
  10. Vitamin KAntimicrobial agents and chemotherapy · 2017
    Article
  11. Antimicrobial Effects of Antipyretics.Antimicrobial agents and chemotherapy · 2017
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Zhangqi ShenDepartment of Veterinary Microbiology and Preventive Medicine, 1116 Veterinary Medicine Complex, Iowa State University, Ames, IA 50011, USA.
Xiao-Ying Pu
Qijing Zhang
Iowa State University · USHangzhou Center for Disease Control and Prevention · CN

Funding

Mechanisms of Antibiotic Efflux in CampylobacterR01DK063008 · NIDDK · IOWA STATE UNIVERSITY · PI ZHANG, QIJING · 2003 to 2011
$2.1M
NIDDK NIH HHS R01 DK063008NIDDK NIH HHS R01DK063008
6 · The paper itself

Abstract

Salicylate, a nonsteroidal anti-inflammatory compound, has been shown to increase the resistance of Campylobacter to antimicrobials. However, the molecular mechanism underlying salicylate-induced resistance has not yet been established. In this study, we determined how salicylate increases antibiotic resistance and evaluated its impact on the development of fluoroquinolone-resistant Campylobacter mutants. Transcriptional fusion assays, real-time quantitative reverse transcription-PCR (RT-PCR), and immunoblotting assays consistently demonstrated the induction of the CmeABC multidrug efflux pump by salicylate. Electrophoretic mobility shift assays further showed that salicylate inhibits the binding of CmeR (a transcriptional repressor of the TetR family) to the promoter DNA of cmeABC, suggesting that salicylate inhibits the function of CmeR. The presence of salicylate in the culture medium not only decreased the susceptibility of Campylobacter to ciprofloxacin but also resulted in an approximately 70-fold increase in the observed frequency of emergence of fluoroquinolone-resistant mutants under selection with ciprofloxacin. Together, these results indicate that in Campylobacter, salicylate inhibits the binding of CmeR to the promoter DNA and induces expression of cmeABC, resulting in decreased susceptibility to antibiotics and in increased emergence of fluoroquinolone-resistant mutants under selection pressure.

Indexed as

Drug Resistance, BacterialAnti-Bacterial AgentsAnti-Inflammatory Agents, Non-SteroidalArtificial Gene FusionBiological Transport, ActiveCampylobacter jejuniDNA, BacterialElectrophoretic Mobility Shift AssayFluoroquinolonesGene Expression ProfilingGenes, ReporterImmunoblottingProtein BindingRepressor ProteinsReverse Transcriptase Polymerase Chain ReactionSalicylatesAnti-Bacterial AgentsAnti-Inflammatory Agents, Non-SteroidalDNA, BacterialFluoroquinolonesRepressor ProteinsSalicylates

Identifiers

PMID21821741
PMCPMC3194847
OpenAlexW1994854747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.